Stock Market Reviews

Read and share opinions on INO (Inovio Pharmaceuticals, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar

Latest News

• Inovio (INO) Upgraded to Buy: Here's Why
  Nov 14, 2025
• Individual investors invested in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) lost 13% last week, institutions remained on the sidelines
  Nov 14, 2025
• INOVIO Announces Pricing of $25 Million Public Offering
  Nov 11, 2025
• Inovio Pharmaceuticals Inc (INO) Q3 2025 Earnings Call Highlights: Strategic Advances Amid ...
  Nov 11, 2025
• INOVIO Announces Proposed Public Offering
  Nov 10, 2025
• Inovio: Q3 Earnings Snapshot
  Nov 10, 2025
• INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights
  Nov 10, 2025
• INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults
  Nov 3, 2025
• INOVIO Reports Inducement Grant Under Inducement Plan
  Oct 31, 2025
• INOVIO to Report Third Quarter 2025 Financial Results on November 10, 2025
  Oct 27, 2025
• INOVIO to Participate in the Stephens Biotechnology Virtual Fireside Chat Conference
  Oct 23, 2025
• Clinical Proof-of-Concept Data for DNA-Encoded Monoclonal Antibodies (DMAbs) Published in Nature Medicine
  Oct 21, 2025
• INOVIO to Participate in Upcoming Scientific Conferences
  Sep 25, 2025
• INO Stock Soars as FDA Backs Rolling BLA for Rare Lung Disease Drug
  Aug 28, 2025
• INOVIO to Begin Rolling Submission of BLA for INO-3107 for the Treatment of RRP in Adults
  Aug 26, 2025
• INOVIO to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
  Aug 25, 2025
• Inovio Pharmaceuticals Second Quarter 2025 Earnings: US$0.61 loss per share (vs US$1.19 loss in 2Q 2024)
  Aug 15, 2025
• Inovio Pharmaceuticals Inc (INO) Q2 2025 Earnings Call Highlights: Strategic Advances and ...
  Aug 13, 2025